Pints AI, a Singapore-based artificial intelligence startup, has raised USD 5.6 million in a pre-Series A funding round led by Tin Men Capital and co-led by SBI Ven Capital. Seeds Capital, NTUitive, SUTD Venture Fund, and Tenity also participated.
Founded in 2021, Pints helps regulated financial institutions deploy AI across critical workflows through its Autothought platform. The platform connects to core systems used by banks and insurers, automates processes such as underwriting, claims, and client onboarding, and generates audit trails for AI-assisted decisions.
The company said 12 financial institutions in Singapore, India, Hong Kong, and the US have used Autothought. It said the platform can reduce underwriting times by up to 40% and onboarding times by up to 70%, based on its own estimates.
The new funds will support Pints’ expansion across Asia Pacific and the Middle East. The company also plans to deepen its governance and audit capabilities for additional regulatory environments, grow its engineering team, and develop Autothought Studio, a toolset that allows institutions to build and manage AI applications internally.
GreatAsic Technology, a Malaysia-based fabless custom chip design company, has raised USD 6.9 million in a pre-Series A round led by Vertex Ventures Southeast Asia and India. Ehsan Kapital and Gobi Partners also participated.
GreatAsic designs custom ASICs (application-specific integrated circuits) and AI system-on-chip platforms for data center, edge AI, and automotive applications. The company is part of Malaysia’s broader push to move beyond semiconductor assembly and testing into chip design.
Headquartered in Penang, with growing R&D operations in Selangor, GreatAsic is led by a team with experience at companies including Altera, Broadcom, Intel, Marvell, and StarFive.
The funds will be used to hire engineers, expand operations, and accelerate the development of its planned silicon projects.
Onibi, an independent game studio building the AI-powered open-world multiplayer role-playing game Tomo: Endless Blue, has secured an undisclosed amount of funding. The round was co-led by SeaX Ventures and Pix Capital.
Onibi is developing multiplayer games where proprietary AI models generate villages, cultures, non-player characters, dialogue, quests, and stories for each player. Tomo: Endless Blue combines AI-driven world generation with physics-based voxel systems, scalable multiplayer infrastructure, and creator tools.
The studio also plans to develop the title into a user-generated content platform, enabling players to create RPG experiences with AI-assisted tools. Its team includes developers and artists who have contributed to franchises such as World of Warcraft, Baldur’s Gate 3, Grand Theft Auto, Fortnite, League of Legends, and Fall Guys.
The funding will support the game’s development toward commercial launch, the studio’s expansion in Southeast Asia, preparations for its alpha launch on Kickstarter, and growth of its engineering and creative teams.
YouLabs, a healthcare platform based in Singapore and Hyderabad, has raised USD 2.6 million in a seed round led by Crane Venture Partners, according to DealStreetAsia. The round marks the first investment from Crane’s new APAC fund and includes participation from Dr Reddy’s Laboratories, Matrix Pharma, and designer Jayanti Reddy.
Founded by Ajay Bulusu, YouLabs is developing healthcare and biotechnology infrastructure focused on preventive health and longevity in India. Its team includes physicians, scientists, engineers, and data specialists working on products that monitor health over time, rather than focusing only on disease treatment. Bulusu is a co-founder of NextBillion.ai, an AI-powered mapping and geospatial technology provider acquired by Velocitor Solutions last year.
The company plans to launch its first product, “150,” later this year. The physician-managed program will focus on preventive health and longevity and will initially grow through referrals. YouLabs is also developing longevity-focused supplements and a health data platform centered on South Asian populations, including a proprietary “longevity score.”
The fresh capital will be used to expand its physician network, scientific team, and technology infrastructure.
If there are any news or updates you’d like us to feature, get in touch with us at: [email protected].
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。